Showing results (211-220 of 243) with videos related to

Sort By:
Pageof 25
Journal of the European Academy of Dermatology and Venereology : JEADV|October 22, 2016
Factors associated with combined hand and foot eczemaT Agner, K Aalto-Korte, K E Andersen, et al.
Contact Dermatitis|February 1, 1987
Contact dermatitis. A reviewK E Andersen, C Benezra, D Burrows, et al.
Contact Dermatitis|August 13, 1999
Contents of fragrance allergens in children's cosmetics and cosmetic-toysS C Rastogi, J D Johansen, T Menné, et al.
Contact Dermatitis|January 5, 1999
Fragrances and other materials in deodorants: search for potentially sensitizing molecules using combined GC-MS and structure activity relationship (SAR) analysisS C Rastogi, J P Lepoittevin, J D Johansen, et al.
Journal of Medicinal Chemistry|November 2, 1999
Synthesis of novel GABA uptake inhibitors. 4. Bioisosteric transformation and successive optimization of known GABA uptake inhibitors leading to a series of potent anticonvulsant drug candidatesK E Andersen, J L Sørensen, P O Huusfeldt, et al.
Contact Dermatitis|November 1, 1995
Patch testing with fragrances: results of a multicenter study of the European Environmental and Contact Dermatitis Research Group with 48 frequently used constituents of perfumesP J Frosch, B Pilz, K E Andersen, et al.
Contact Dermatitis|January 5, 2001
Identification of Lilial as a fragrance sensitizer in a perfume by bioassay-guided chemical fractionation and structure-activity relationshipsE G Arnau, K E Andersen, M Bruze, et al.
Contact Dermatitis|May 1, 1990
Patch testing with the "sesquiterpene lactone mix": a marker for contact allergy to Compositae and other sesquiterpene-lactone-containing plants. A multicentre study of the EECDRGG Ducombs, C Benezra, P Talaga, et al.
Contact Dermatitis|June 6, 2003
Deodorants: an experimental provocation study with hydroxycitronellalC Svedman, M Bruze, J D Johansen, et al.
Journal of Medicinal Chemistry|June 11, 1993
The synthesis of novel GABA uptake inhibitors. 1. Elucidation of the structure-activity studies leading to the choice of (R)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic acid (tiagabine) as an anticonvulsant drug candidateK E Andersen, C Braestrup, F C Grønwald, et al.
Pageof 25